OSE Immunotherapeutics: Leadership to Meet with Investors
OSE Immunotherapeutics announces its participation in two investor conferences scheduled for spring 2026. The management will present the company and meet with wealth managers, financial advisors, and investors.
OSE Immunotherapeutics will attend the 'Mardi de la Bourse - Lyon Pôle Bourse' on April 7, 2026, in Lyon, and the 14th Degroof Petercam Healthcare Conference on May 6, 2026, which will be held in a virtual format. Marc Le Bozec, CEO, will lead the presentations at both events and will be joined by Thomas Gidoin, CFO, for Q&A sessions and meetings with investors.
Engaging with a Diverse Investor Base
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
At the Lyon forum, the company will meet with wealth managers, financial advisors, and individual investors. During the Degroof Petercam conference, discussions will primarily involve the professional investor community.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
